Company / Debt per Share
Akebia Therapeutics, Inc. Debt per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.21
FY2025
5-year range
$0.00 / $0.37
FY2021-FY2025
Trend
+7.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Debt per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2021 to $0.79 in FY2020.
Based on SEC 10-K filings.
0.21 in FY2025 with a 5-year CAGR of -23.0%.
Increased from $0.19 to $0.21 over the past 2 years.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -16.9%
- 5-Year CAGR
- -23.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, debt per share increased 7.9% year-over-year.
- Peak debt per share was recorded in FY2020.
- Lowest debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | +7.9% |
| FY2024 | $0.20 | +5.6% |
| FY2023 | $0.19 | -49.5% |
| FY2022 | $0.37 | - |
| FY2021 | $0.00 | -100.0% |
| FY2020 | $0.79 | +22.1% |
| FY2019 | $0.65 | - |
| FY2018 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026